Biomaterials Engineering and Testing core (BET)

III期生物材料工程和测试（BET）核心将支持合成和表征 生物材料和生物材料系统的设计研究项目的重点是发展， 转化再生医学在人类疾病治疗中的应用。BET核心将提供 提供这种研究支持以及培训和指导所需的设施和工作人员， 设施用户。BET核心将建立在其过去9年提供此类支持的记录基础上。 根据COBRE第一和第二阶段的赠款，该公司将在2015年获得2015年的资金，并将大幅提高其生物反应器系统设计的设施， 开发和生物制造，以支持由 翻译研究成像（TRI）核心。在过去的第一阶段和第二阶段COBRE计划中，BET核心已经 提供设施和支持，为出版300多份被引用的期刊出版物做出贡献 我们的几位初级研究人员成功地获得了独立的NIH R01基金。下 在第三阶段计划中，我们的目标是将BET核心开发成可持续的资源， 继续支持转化再生医学研究远远超出第三阶段赠款期。

The Phase III Biomaterials Engineering and Testing (BET) Core will support the synthesis and characterization of biomaterials and the design of biomaterial systems for research projects focused on the development of translational regenerative medicine applications for the treatment of human disease. The BET Core will provide both the facilities and staff necessary to provide this research support as well as training and mentoring for facilities users. The BET Core will build upon its track record of providing this type of support over the past 9 years under the Phase I & II COBRE grants and will substantial enhance its facilities for bioreactor system design, development, and biofabrication in order to support the extended in vivo research services to be offered by the Translational Research Imaging (TRI) Core. Over the past Phase I and II COBRE programs, the BET core has provided the facilities and support contributing to the publication of over 300 referred journal publications as well as the success of several of our junior investigators for attaining their own independent NIH R01 funding. Under the Phase III program, it is our objective to develop the BET Core into a sustainable resource to provide facilities for the continued support of translational regenerative medicine research well beyond the Phase III grant period.